AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glicra M 60mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Ellora Pharma Pvt Ltd

Salt Composition

Gliclazide (60mg) + Metformin (500mg)

Overview Glicra M 60mg/500mg Tablet

Diabetic patients utilizing Glicra M 60mg/500mg tablets, classified as antidiabetic agents, receive a dual-medicine formulation for managing type 2 diabetes mellitus. This combination medication effectively regulates blood glucose in adult patients. Administer Glicra M with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood glucose response. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb impairment. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle modifications significantly influence diabetes control. Common adverse effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Always carry a readily available glucose source (e.g., sugary snacks, fruit juice) to counter hypoglycemic episodes, and maintain regular mealtimes. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional side effects may include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is also a possibility. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Uses of Glicra M 60mg/500mg Tablet

Diabetes mellitus type 2

Major Benefits of Glicra M 60mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Glicra M 60mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

Common Side effects of Glicra M 60mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glicra M 60mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Glicra M 60mg/500mg tablets should be administered with food.

How Glicra M 60mg/500mg Tablet works:

Each Glicra M 60mg/500mg tablet combines the antidiabetic agents gliclazide (60mg) and metformin (500mg).

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Glicra M 60mg/500mg Tablet use is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glicra M 60mg/500mg tablets during pregnancy poses a confirmed risk to the fetus. Prescribing this medication during pregnancy is uncommon, reserved only for life-threatening conditions where potential benefits clearly outweigh the risks. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glicra M 60mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Glicra M 60mg/500mg tablets, potentially requiring dosage modification. Consult a physician for guidance. Glicra M 60mg/500mg tablets are contraindicated in patients with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glicra M 60mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, initiation with a low dose is typical; however, it's contraindicated in severe cases.

What if you forget to take Glicra M 60mg/500mg Tablet :

Should you forget a Glicra M 60mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glicra M 60mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glicra M 60mg/500mg Tablet

Glicra M 60mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This treatment improves blood sugar control when used with a healthy diet and exercise. Gliclazide boosts insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Glicra M 60mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glicra M 60mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Glicra M 60mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glicra M 60mg/500mg Tablets and seek immediate medical attention.
Prolonged use of Glicra M 60mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), cognitive changes, and balance problems (ataxia). To mitigate this risk, supplemental vitamin B12 intake, at least annually, is recommended by some researchers.
Glicra M 60mg/500mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. They should also be avoided in those with moderate to severe kidney disease or metabolic acidosis, such as diabetic ketoacidosis.
Combining alcohol with Glicra M 60mg/500mg tablets is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Glicra M 60mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This treatment improves blood sugar control when combined with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glicra M 60mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glicra M 60mg/500mg Tablets can cause low blood sugar (hypoglycemia), resulting in symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Glicra M 60mg/500mg Tablets can cause lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is characterized by high blood lactic acid levels. It's crucial to avoid use in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Glicra M 60mg/500mg Tablets and seek immediate medical attention.
Prolonged use of Glicra M 60mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glicra M 60mg/500mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. They should also be avoided in those with moderate to severe kidney disease or metabolic acidosis, such as diabetic ketoacidosis.
Consuming alcohol while taking Glicra M 60mg/500mg is unsafe. It can worsen low blood sugar and raise the risk of lactic acidosis.
Glicra M 60mg/500mg Table...
85
MRP 104
18% off